Johnson & Johnson: Pharmaceutical Fireworks at J&J! Strong Numbers, Clear Strategy, Rising Margins!
Reading Time: 3 minutes
The new reporting season kicks off this week with the banking sector and individual companies from other areas. In the "Healthcare" sector, Johnson & Johnson leads the way. With a monthly performance of over 8%, the company is the sector leader in the "Drug Manufacturers – General" industry. We want to take a closer look at the business report and discuss the forecasts. J&J focuses on pharmaceuticals and medical technology Orthopedics spin-off from DePuy Synthes expected to further enhance margins Growth of more than 5% expected in fiscal...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

